NCT02682901View on ClinicalTrials.gov

Bromocriptine-QR Therapy on Sympathetic Tone and Vascular Biology in Type 2 Diabetes Subjects

PHASE4CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

October 5, 2015

Primary Completion Date

November 15, 2018

Study Completion Date

November 15, 2018

Conditions
Diabetic Autonomic Neuropathy
Interventions
DRUG

Cycloset

Cycloset 1.6 -3.2 mg/day

DRUG

Placebo

Non-active placebo for cycloset

Trial Locations (1)

23510f

Eastern Virgnia Medical School, Strelitz Diabetes Center, Norfolk

All Listed Sponsors
lead

Eastern Virginia Medical School

OTHER

NCT02682901 - Bromocriptine-QR Therapy on Sympathetic Tone and Vascular Biology in Type 2 Diabetes Subjects | Biotech Hunter | Biotech Hunter